BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6602679)

  • 21. Analysis of sera from ovarian cancer patients for immune complexes.
    Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
    J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune complexes in congenital and natal cytomegalovirus infections of man.
    Stagno S; Volanakis JE; Reynolds DW; Stroud R; Alford CA
    J Clin Invest; 1977 Oct; 60(4):838-45. PubMed ID: 197126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A.
    McDougal JS; Redecha PB; Inman RD; Christian CL
    J Clin Invest; 1979 Apr; 63(4):627-36. PubMed ID: 438327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
    Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
    Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of a binding reactivity of human C-reactive protein for immunoglobulin or immune complexes.
    Ballou SP; Macintyre SS
    J Lab Clin Med; 1990 Mar; 115(3):332-8. PubMed ID: 2107267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating immune complexes in sera of patients infected with Echinococcus granulosus.
    Pini C; Pastore R; Valesini G
    Clin Exp Immunol; 1983 Mar; 51(3):572-8. PubMed ID: 6406114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-fixing material in ther sera of patients with rheumatoid arthritis.
    McDuffie FC; Hunder GG; Clark RJ
    Clin Exp Immunol; 1978 May; 32(2):218-25. PubMed ID: 668197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anomalous Raji cell activity related to DNA binding in some patients with autoimmune disease.
    Levinson SS; Goldman J
    Clin Physiol Biochem; 1989; 7(1):18-26. PubMed ID: 2752670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a tumor-related protein antigen in immune complexes derived from pleural effusions of patients with bronchial carcinoma.
    Lawniczak M; Jezewska E; Górny MK; Zeromski J
    Neoplasma; 1985; 32(1):9-20. PubMed ID: 3982564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes in human osteosarcoma.
    Tsang KY; Singh I; Blakemore WS
    J Natl Cancer Inst; 1979 Apr; 62(4):743-8. PubMed ID: 285287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma.
    Barkas T; AL-Khateeb SF; Irvine WJ; Davidson NM; Roscoe P
    Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1983 Aug; 53(2):308-18. PubMed ID: 6411401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of low m.w., C3-bearing immunoglobulin in human serum.
    Jacobs RJ; Reichlin M
    J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.